Back

Strong Protection by Bazedoxifene Against Chemically-Induced Ferroptotic Neuronal Death In Vitro and In Vivo

Hao, X.; Wang, Y.; Yang, Y. X.; Chen, T.; Wang, P.; Zhu, B. T.

2024-05-31 neuroscience
10.1101/2024.05.26.595988 bioRxiv
Show abstract

Ferroptosis is a form of regulated cell death characterized by excessive iron-dependent lipid peroxidation. Ferroptosis can be induced in cultured cells by exposure to certain chemicals (e.g., erastin and RSL3). Recently it was shown that protein disulfide isomerase (PDI) is a mediator of chemically-induced ferroptosis and also a target for ferroptosis protection. In this study, we find that bazedoxifene (BAZ), a selective estrogen receptor modulator with reported neuroprotective actions in humans, can inhibit PDI function and also strongly protect against chemically-induced ferroptosis in cultured neuronal cells. We find that BAZ can directly bind to PDI in vitro and in intact neuronal cells, and also can inhibit PDIs catalytic activity. Computational modeling analysis reveals that BAZ forms a hydrogen bond with PDI-His256. Inhibition of PDI by BAZ markedly reduces nNOS and iNOS dimerization and NO accumulation, which have recently been shown to play a crucial role in mediating chemically-induced ferroptosis. In addition, the direct antioxidant activity of BAZ may also partially contribute to its protective effect against chemically-induced ferroptosis. Behavioral analysis shows that mice treated with BAZ are strongly protected against kainic acid-induced memory deficits and hippocampal neuronal damage in vivo. In conclusion, the results of this study demonstrate that BAZ is an inhibitor of PDI and can strongly prevent chemically-induced ferroptosis in hippocampal neurons both in vitro and in vivo. These observations offer a novel, estrogen receptor-independent mechanism for the recently-reported neuroprotective actions of BAZ in humans. SIGNIFICANCE STATEMENTFerroptosis is an iron- and lipid peroxidation-dependent form of regulated cell death. Recent evidence has shown that protein disulfide isomerase (PDI) is an important mediator of chemically-induced ferroptosis and also a new target for ferroptosis protection. We find that bazedoxifene is an inhibitor of PDI, which can strongly protect against chemically-induced ferroptotic neuronal death in vitro and in vivo. Additionally, the molecular mechanism of PDI{square}bazedoxifene binding interaction is defined. This work provides evidence for an estrogen receptor-independent, PDI-mediated mechanism of neuroprotection by bazedoxifene.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Acta Biochimica et Biophysica Sinica
23 papers in training set
Top 0.1%
26.4%
2
Cell Death & Disease
126 papers in training set
Top 0.2%
7.8%
3
eLife
5828 papers in training set
Top 24%
5.1%
4
ACS Chemical Neuroscience
67 papers in training set
Top 0.2%
4.3%
5
Journal of Biological Chemistry
690 papers in training set
Top 2%
4.3%
6
International Journal of Molecular Sciences
494 papers in training set
Top 3%
4.0%
50% of probability mass above
7
Redox Biology
70 papers in training set
Top 0.4%
3.2%
8
Advanced Science
286 papers in training set
Top 3%
2.4%
9
Cells
249 papers in training set
Top 2%
1.9%
10
Scientific Reports
3612 papers in training set
Top 51%
1.9%
11
Cell Death Discovery
58 papers in training set
Top 0.5%
1.7%
12
iScience
1154 papers in training set
Top 20%
1.5%
13
The FASEB Journal
194 papers in training set
Top 3%
1.5%
14
Antioxidants
25 papers in training set
Top 0.3%
1.4%
15
PLOS ONE
5266 papers in training set
Top 52%
1.4%
16
Biomolecules
100 papers in training set
Top 1%
1.3%
17
Neuroscience Bulletin
12 papers in training set
Top 0.1%
1.1%
18
Biomedicine & Pharmacotherapy
42 papers in training set
Top 1.0%
1.1%
19
Molecular and Cellular Neuroscience
20 papers in training set
Top 0.3%
1.1%
20
Free Radical Biology and Medicine
36 papers in training set
Top 0.5%
1.1%
21
Frontiers in Pharmacology
111 papers in training set
Top 2%
1.1%
22
Molecular Brain
28 papers in training set
Top 0.5%
0.8%
23
Brain Research
38 papers in training set
Top 0.8%
0.8%
24
British Journal of Pharmacology
40 papers in training set
Top 0.9%
0.8%
25
Communications Biology
993 papers in training set
Top 30%
0.8%
26
Journal of Neurochemistry
53 papers in training set
Top 2%
0.6%
27
European Journal of Pharmacology
15 papers in training set
Top 0.8%
0.6%
28
Theranostics
37 papers in training set
Top 1%
0.6%
29
ACS Omega
105 papers in training set
Top 4%
0.6%
30
Molecular Neurobiology
53 papers in training set
Top 2%
0.6%